report decent result small miss coupl big sg beat
commerci growth bright spot demonstr compani effort drive
growth segment traction primari focu continu launch
ingeniorx may begin earnest valuat compel ep
pois exceed growth
lower adj ep estim increas estim
better reflect invest spend earn flow associ
ingeniorx estim repres full year adj ep
earn compris slightli in-lin compani comment
approach rang earn revis due higher invest
spend relat ingeniorx lower benefit favor risk adjust true up
recal result benefit risk adjust receiv base
membership compani individu enrol shrank approxim
member y/i suggest magnitud risk adjust true up associ
earn impact like much smaller
vast major member migrat ingeniorx expect
accordingli major earn benefit also realiz
potenti small portion come estim
benefit ramp respect biggest
sourc uncertainti regard time benefit relat medicaid need
secur approv state convers compani suggest
receiv approv sever state subsequ investor day
none unclear certain state transit state
still outstand still compani continu expect state client fulli
transit januari
provid much detail iowa medicaid membership would
alloc assum compani receiv equal
market share receiv member estim could
worth increment revenu analysi compani
statutori file suggest perform slightli better iowa medicaid
vs recogn meaning differ
report howev believ rate updat coupl improv
pharmaci cost structur ingenio could help improv perform iowa gener
believ transit ingenio could help allevi margin pressur
medicaid
manag consist emphas import reinvigor commerci
specialti growth demonstr strong perform across portfolio
commerci risk-bas membership grew sever year shrink enrol
pleas see page report import disclosur
much focu head center roll-out pbm ingeniorx
compani expect ingeniorx gener annual run-rat cost save
approxim worth ep accru sharehold fulli
transit compani acceler timelin ingeniorx termin
contract express script earli begin transit client
ingeniorx platform march vs previou expect januari earli
transit associ improv drug purchas econom estim worth
increment ep compani expect achiev full run-
rate save target end believ could posit compani
acceler commerci risk medicar advantag growth beyond
transit ingeniorx platform may
repres
bp y/i
grow faster expect
lower expect cost save
delay associ ingeniorx
health benefit compani serv million medic member
decemb manag oper three segment commerci
specialti govern independ license cross
shield associ bcbsa associ independ health benefit plan offer
spectrum network-bas manag care plan larg small employ individu
medicaid senior market build pharmaci benefit manag
ingeniorx expect begin serv member may
maintain price target impli price-to-earnings multipl adj
ep estim believ pois deliv earn growth excess
meet top bottom-lin guidanc beyond depend
drive growth ingeniorx believ risk/reward attract less
ep reiter outperform
million except per-shar data
cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end decemb cowen
million except per-shar data
compani report cowen compani
expens expens ratio expens sg ex non-recur ratio ex non-recur tax add back hif-rel tax rate pre-tax hif-rel tax share o/ amort ep ex chang year-over-year premium sg ex non-recur ex non-recur end decemb cowen
million except per-shar data
compani report cowen compani
revenu premium expens expens ratio product product expens expens sg ex non-recur ratio ex non-recur oper tax add back hif-rel tax rate pre-tax hif-rel tax expens tax rate incom share o/ amort ep ex net incom chang year-over-year premium revenu cowen
million
cowen compani
assetscash cash term tax tax invest lend held current current assetsproperti equip intang term liabilitiesunpaid life accid polici policyhold accru tax trade pend portion long-term debt short-term lend held current current liabilitieslong-term debt benefits/reserv futur polici tax non-current equitycommon paid comprehens sharehold liabil sharehold liquid ratio current receiv claim payabl capit structur long-term solvenc ratio return invest capit averag total asset averag stockhold equiti end decemb cowen
million
compani report cowen compani
oper activitiesnet gain net properti equip impair gain extinguish gain sale incom tax benefit share-bas loss discontinu oper asset polici liabilities/ medic unearn account payabl accru incom taxes- oper proce purchas secur asset proce repay debt acquisit /disposit netpurchas properti equip common stock dividend chang secur lend collater payabl net- non-curr begin net increas decreas end year end decemb cowen
compani report cowen compani
oper activitiesnet gain impair gain extinguish sale incom net tax benefit share-bas loss discontinu properti oper asset invest polici liabilities/ medic unearn account payabl accru incom net oper invest activitiespurchas fix matur proce fix matur matur call purchas equiti proce sale equiti purchas invest proce sale invest settlement non-hedg chang secur lend purchas subsidiari net cash acquired- proce sale subsidiari net cash purchas properti proce sale properti net invest financ activitiesnet proce repay commerci proce long-term repay long-term proce short-term repay short-term chang secur lend chang bank premium paid equiti call options- proce sale put options- common stock proce issuanc common chang collater settlement debt-rel derivatives- dividend tax paid withhold common stock esp- excess tax benefit share-bas net financ net effect foreign begin net increas decreas end year end decemb cowen
valu manag care stock use pe multipl forward earn manag care
sector trade averag forward year earn past year
peak trough troubl econom time
frame given reform-rel multi-year top-lin growth prospect believ sector
trade high end recent histor valuat
success individu public exchang remain consider question mark
head third year program final year two three premium
stabil program reinsur risk corridor although exchang profit
expect improv expect continu money lose enterpris
industri particip receipt risk corridor payment remain potenti threat
success compani reli receiv medicar advantag payment
reduct includ potenti introduct new risk adjust model could
reduc futur medicar advantag margin growth prospect rel expect
gener medicaid payment expans popul gener
howev mount evid state like reduc payment level
medic cost trend mute past year uptick underli
medic cost may difficult predict product price within commerci
medicar market said believ insul given histor
blue aggress price would impact except
transit ingeniorx could take longer expect addit amount
compani believ gain save could come current estim
could turn impact amount expect revert sharehold
possibl transit time exce month could result higher cost
and/or delay realiz full save benefit improv pharmaci cost
